Literature DB >> 15674655

Comparison of early and late pleuropulmonary findings of ankylosing spondylitis by high-resolution computed tomography and effects on patients' daily life.

Remzi Altin1, Senay Ozdolap, Ahmet Savranlar, Selda Sarikaya, Meltem Tor, Levent Kart, Hüseyin Ozdemir.   

Abstract

Ankylosing spondylitis (AS) is a multisystemic disease and extra-articular features may develop as pleuropulmonary involvement. We aimed to show and compare the early and late pleuropulmonary findings of AS and its effects on patients' daily life by causing dyspnea. The study consisted of 38 patients (33 male, 5 female). All patients met the New York criteria for AS. Patients were divided into two groups for comparison of early (disease duration <10 years and normal chest X-ray, 18 patients) and late (disease duration >/=10 years and normal or abnormal chest X-ray, 20 patients) manifestations. All patients underwent high-resolution computed tomography (HRCT) and pulmonary function tests. A questionnaire was completed to measure perceived shortness of breath (dyspnea score) with activities of daily living such as dressing, shaving or walking. HRCT findings were abnormal in 27 of the 38 patients (73%). Pulmonary involvement was high in early AS (61.1%). The number of findings in early and late AS found were as follows: mosaic pattern (9/10), parenchymal micronodules (2/3), parenchymal bands (5/9), bronchial wall thickening (2/10), ground-glass opacity (7/7), and interlobular septal thickening (6/10). A moderate correlation was obtained between presence of mosaic pattern and forced midexpiratory flow rate (FEF(25-75)) values indicating small airway obstruction (r=0.346, p=0.019). The dyspnea score was statistically higher in patients with AS having pulmonary involvement than those without involvement. Pulmonary involvement is common in early AS compared to late AS. The involvement of small airways was found frequently as interstitial lung disease in early and late AS. This study also suggests that AS with pulmonary involvement may affect patients' daily life by causing dyspnea, which is why early detection of pulmonary lesions may have clinical importance and should be studied in a large cohort.

Entities:  

Mesh:

Year:  2004        PMID: 15674655     DOI: 10.1007/s10067-004-0960-1

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  30 in total

Review 1.  Sulphasalazine and lung toxicity.

Authors:  S D Parry; C Barbatzas; E T Peel; J R Barton
Journal:  Eur Respir J       Date:  2002-04       Impact factor: 16.671

2.  Glossary of terms for CT of the lungs: recommendations of the Nomenclature Committee of the Fleischner Society.

Authors:  J H Austin; N L Müller; P J Friedman; D M Hansell; D P Naidich; M Remy-Jardin; W R Webb; E A Zerhouni
Journal:  Radiology       Date:  1996-08       Impact factor: 11.105

Review 3.  Pulmonary involvement in the collagen vascular diseases.

Authors:  G W Hunninghake; A S Fauci
Journal:  Am Rev Respir Dis       Date:  1979-03

4.  Chronic diffuse infiltrative lung disease: comparison of diagnostic accuracy of CT and chest radiography.

Authors:  J R Mathieson; J R Mayo; C A Staples; N L Müller
Journal:  Radiology       Date:  1989-04       Impact factor: 11.105

5.  Lung findings on high-resolution computed tomography in idiopathic ankylosing spondylitis--correlation with clinical findings, pulmonary function testing and plain radiography.

Authors:  I P Casserly; H M Fenlon; E Breatnach; S M Sant
Journal:  Br J Rheumatol       Date:  1997-06

Review 6.  The seronegative spondyloarthropathies.

Authors:  J M Kettering; J D Towers; D A Rubin
Journal:  Semin Roentgenol       Date:  1996-07       Impact factor: 0.800

7.  A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index.

Authors:  A Calin; S Garrett; H Whitelock; L G Kennedy; J O'Hea; P Mallorie; T Jenkinson
Journal:  J Rheumatol       Date:  1994-12       Impact factor: 4.666

8.  The Bath Ankylosing Spondylitis Radiology Index (BASRI): a new, validated approach to disease assessment.

Authors:  K MacKay; C Mack; S Brophy; A Calin
Journal:  Arthritis Rheum       Date:  1998-12

9.  CT of interstitial lung disease: a diagnostic approach.

Authors:  C J Bergin; N L Müller
Journal:  AJR Am J Roentgenol       Date:  1987-01       Impact factor: 3.959

Review 10.  Pulmonary disease due to antirheumatic agents.

Authors:  R J Zitnik; J A Cooper
Journal:  Clin Chest Med       Date:  1990-03       Impact factor: 2.878

View more
  10 in total

Review 1.  [Pulmonary manifestations in rheumatic systemic diseases].

Authors:  T Schlossbauer; C Becker-Gaab; R Eibel
Journal:  Radiologe       Date:  2005-07       Impact factor: 0.635

2.  Pulmonary involvement in ankylosing spondylitis.

Authors:  Percival D Sampaio-Barros; Elza Maria F P Cerqueira; Sílvio M Rezende; Lucimara Maeda; Roseneide A Conde; Verônica A Zanardi; Manoel Barros Bértolo; José Ribeiro de Menezes Neto; Adil M Samara
Journal:  Clin Rheumatol       Date:  2006-03-30       Impact factor: 2.980

Review 3.  Pulmonary, renal and neurological comorbidities in patients with ankylosing spondylitis; implications for clinical practice.

Authors:  Cecilia Mercieca; Irene E van der Horst-Bruinsma; Andrew A Borg
Journal:  Curr Rheumatol Rep       Date:  2014-08       Impact factor: 4.592

4.  Lung parenchymal changes in patients with ankylosing spondylitis.

Authors:  Zehra Isik Hasiloglu; Nuri Havan; Aylin Rezvani; Mustafa Akif Sariyildiz; Halil Eren Erdemli; Ilhan Karacan
Journal:  World J Radiol       Date:  2012-05-28

5.  [A comparison of respiratory muscle strength, pulmonary function tests and endurance in patients with early and late stage ankylosing spodylitis].

Authors:  G Sahin; H Guler; M Calikoglu; M Sezgin
Journal:  Z Rheumatol       Date:  2006-10       Impact factor: 1.372

6.  Pulmonary abnormalities on high-resolution computed tomography in ankylosing spondylitis: relationship to disease duration and pulmonary function testing.

Authors:  Oya Ozdemir; Meltem Gülsün Akpınar; Fatma Inanıcı; H Zafer Hasçelik
Journal:  Rheumatol Int       Date:  2011-04-09       Impact factor: 2.631

7.  Spinal mobility, vertebral squaring, pulmonary function, pain, fatigue, and quality of life in patients with ankylosing spondylitis.

Authors:  Hyungpil Cho; Taikon Kim; Tae-Hwan Kim; Seunghun Lee; Kyu Hoon Lee
Journal:  Ann Rehabil Med       Date:  2013-10-29

8.  Prevalence and characteristics of lung involvement on high resolution computed tomography in patients with ankylosing spondylitis: a systematic review.

Authors:  Abdellah El Maghraoui; Mohamed Dehhaoui
Journal:  Pulm Med       Date:  2012-02-22

9.  The results of purified protein derivative test in ankylosing spondylitis patients: clinical features, HRCT results and relationship with TNF-blocker usage.

Authors:  Omer Nuri Pamuk; Yusuf Yesil; Salim Donmez; Ercüment Unlü; Ibrahim Hakki Köker; Necati Cakir
Journal:  Rheumatol Int       Date:  2008-08-06       Impact factor: 3.580

10.  Restrictive pulmonary function is more prevalent in patients with ankylosing spondylitis than in matched population controls and is associated with impaired spinal mobility: a comparative study.

Authors:  Gunnhild Berdal; Silje Halvorsen; Désirée van der Heijde; Morten Mowe; Hanne Dagfinrud
Journal:  Arthritis Res Ther       Date:  2012-01-25       Impact factor: 5.156

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.